Results 61 to 70 of about 271 (119)

The influence of prior obstetrical history on current 17-hydroxyprogesterone caproate use. [PDF]

open access: yesJ Pregnancy, 2011
Ransom CE   +5 more
europepmc   +1 more source

Progesterone Metabolites Produced by Cytochrome P450 3A Modulate Uterine Contractility in a Murine Model. [PDF]

open access: yesReprod Sci, 2015
Patil AS   +5 more
europepmc   +1 more source

What we have learned about the role of 17-alpha-hydroxyprogesterone caproate in the prevention of preterm birth. [PDF]

open access: yesSemin Perinatol, 2016
Caritis SN   +4 more
europepmc   +1 more source

Quality assessment of compounded 17-hydroxyprogesterone caproate. [PDF]

open access: yesAm J Obstet Gynecol, 2014
Chang J   +5 more
europepmc   +1 more source

Pharmacogenomics of 17-alpha hydroxyprogesterone caproate for recurrent preterm birth prevention. [PDF]

open access: yesAm J Obstet Gynecol, 2014
Manuck TA   +7 more
europepmc   +1 more source

Predictors of response to 17-alpha hydroxyprogesterone caproate for prevention of recurrent spontaneous preterm birth. [PDF]

open access: yesAm J Obstet Gynecol, 2016
Manuck TA   +13 more
europepmc   +1 more source

Profiles of 21-Carbon Steroids in 21-hydroxylase Deficiency.

open access: yesJ Clin Endocrinol Metab, 2015
Turcu AF   +9 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy